When you say sponsors should think of their clinical protocols as “data”, what do you mean? For a lot of non-data-scientists, the word “data” typically conjures up images of numbers and spreadsheets.

New guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents ...

When discussing the future of clinical trials, people often focus on the promise of exciting new technologies, including artificial intelligence (AI) and predictive modeling. However, even the most ...

A multi-disciplinary team of UPMC clinicians has developed comprehensive clinical protocols for managing hospitalized patients exposed to xylazine—a veterinary sedative increasingly found in the ...

In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date The ...

Insurers limit the use of certain prescription drugs by requiring step therapy—that is, by allowing access only after alternatives have been tried and have failed. Using data from seventeen of the ...

As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...

This is read by an automated voice. Please report any issues or inconsistencies here. Cubital tunnel syndrome is the second most common compression mononeuropathy in the upper extremity.

The National Comprehensive Cancer Network guidelines for pediatric and adult acute lymphoblastic leukemia (ALL) provide recommendations on standard treatment approaches based on the current evidence.

The flowchart and steps below outlines the best practice for processing industry-written and sponsored clinical trials at UAB. There are many small steps in each of the larger defined steps (see flow ...

Recently, the Korean Patent Court rendered a favourable decision on the patentability of medical use inventions in which strict scrutiny was employed for two aspects of the enablement and ...